| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.003 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |